Evidence 1
Activity
Activity
0.27±0.44% Hemolysis
Toxicity
6.25 µM
Hemolytic
Cytotoxic
0.27±0.44% Hemolysis | 6.25 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
A QSAR modeling approach for predicting myeloid antimicrobial peptides with high sequence similarity. | Chem Biol Drug Des | 2020